TVGN
TVGN
NASDAQ · Biotechnology

Tevogen Bio Holdings Inc

$5.90
-0.40 (-6.35%)
As of Nov 21, 2:47 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +255.3% upside
Low Target $15.05
Average Target $20.96
High Target $24.54
Current Price $5.90
Current
$5.90
Target
$20.96
$15.05 $20.96 avg $24.54
Scenario Analysis
Bear Case
$15.05
155.1%
Low target
Base Case
$20.96
+255.3%
Avg target
Bull Case
$24.54
+315.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$24.90
-76.3% from high
52-Week Low
$3.64
+62.2% from low
Target vs 52W High
$20.96
-15.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -10.0%
AMGN
Amgen Inc
Hold 42 43% $190.87 -56.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +117.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.7%
MRNA
Moderna Inc
Hold 31 32% $149.45 -23.4%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -47.7%
BIIB
Biogen Inc
Buy 44 73% $91.45 -63.4%